Availability of Prostin® E2

HPS Pharmacies wish to advise that Pfizer is experiencing a supply interruption for Prostin^® E2 as follows:

Prostin^® E2 Vaginal Gel
Dinoprostone 1mg
ARTG 9983 

Prostin^® E2 Vaginal Gel
Dinoprostone 2mg
ARTG 9984

Normal supplies are expected to resume by the end of June 2026.

An internationally registered alternative of each strength has been approved for supply under Section 19A of the Therapeutic Goods Act 1989. However, these products are not yet available for immediate supply. Updates will be provided when more information becomes available.

No equivalent products are currently available. Potential alternatives that prescribers may consider include dinoprostone controlled-release pessary (Cervidil^®), oxytocin, and misoprostol. Availability of these products may vary throughout the country.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Pfizer on 1800 675 229, or your pharmacist at HPS Pharmacies.

Download PDF